SecProbe.io - Probe Score Transparency

Probe Score Transparency

Anika Therapeutics, Inc. (ANIK)
Score window: May. 30, 2025 to May. 29, 2026

Back View Correspondence

Probe Score

4.6 / 10

Letters

2

Latest Activity

Feb. 26, 2026

Version

v1

Score Breakdown

Letter Count

2.0

Sentiment / Tone

1.5

Keywords

0.0

Signals

0.0

Notable 8-K Modifier

1.1

Notable 8-K Count

2

Matched Signals

No stored keyword or signal matches were recorded for this score.

Filings In This Window

Date	Form	Sentiment	Urgency	Summary	Open
Jul. 24, 2025	UPLOAD	Neutral/Informational	Low	The SEC has completed its review of Anika Therapeutics, Inc.'s Form 10-K for the fiscal year ended December 31, 2024. They remind the company and its management that they are resp…	Read Filing EDGAR
Jul. 17, 2025	CORRESP	Concern from SEC	Moderate	Anika Therapeutics, Inc. submitted a response to the SEC's comments regarding their Form 10-K for the fiscal year ended December 31, 2024. The SEC raised concerns about the compan…	Read Filing EDGAR
Jun. 18, 2025	UPLOAD	Concern from SEC	High	The SEC has issued comments regarding Anika Therapeutics, Inc.'s Form 10-K for the fiscal year ended December 31, 2024. The comments focus on the need for more detailed disclosure…	Read Filing EDGAR

Notable 8-Ks In This Window

No notable 8-Ks were stored for this company in the score window.